From Veterinary Clinics to Biotech: How Innovation is Transforming Animal Health in Spain

For years, veterinary medicine was perceived as a field exclusively linked to traditional clinical care. However, that view has changed dramatically. The combination of new consumer habits, technological advances, and a growing concern for animal welfare is driving a profound transformation in animal health, turning it into one of the most dynamic segments within the broader healthcare and life sciences ecosystem. The global pet care market is already estimated at over $250 billion, with sustained growth expected at high single-digit CAGR in many developed markets, reflecting a structural shift from basic care to increasingly sophisticated medical demand.

Today, we are looking at a more sophisticated and demanding market, with a rising need for advanced solutions. Pet owners are seeking increasingly specialized, minimally invasive treatments supported by scientific evidence, a trend that mirrors developments in human healthcare. In parallel, studies in veterinary economics show a consistent increase in average spending per animal over the last decade in Europe and North America, particularly in preventive care and specialist procedures. At the same time, veterinary hospitals and clinics are evolving toward more professionalized models, incorporating new technologies, specialized teams, and high-value services such as advanced imaging, surgery, and continuous monitoring.

In this context, animal health is no longer just a care-focused sector, but also a space for business development, technology transfer, and the creation of companies with strong global potential. The increasing complexity of clinical needs, combined with the gradual digitalization of veterinary workflows—still unevenly adopted, with some studies suggesting that a significant share of clinics have limited access to fully integrated digital and imaging systems—is opening the door to new business models and investment opportunities across devices, diagnostics, software, and specialized services.

Key trends reshaping the sector

Veterinary innovation is advancing in parallel with many of the trends already transforming human medicine. Among the most relevant are:

• Minimally invasive surgery, with safer procedures and reduced recovery times
• Advanced diagnostics, supported by medical imaging, precision analytics, and digital tools
• Specialized medical devices, designed specifically for veterinary pathologies
• Digitalization of clinical processes, from medical records to remote monitoring
• New care models, focused on prevention and animal quality of life

All of this responds to a clear reality: the bond between people and their pets has strengthened significantly, with surveys consistently showing that a large majority of pet owners in developed markets now consider their animals as family members, directly influencing willingness to invest in advanced healthcare solutions.

A growing global innovation landscape

Across the international ecosystem, universities, research centers, startups, and established companies are generating solutions with strong scientific foundations and significant global potential. Veterinary R&D activity has increased steadily in recent years, particularly in areas such as medical devices, biotechnology, and digital health, reflecting the convergence between animal health and broader medtech and life sciences innovation.

The transfer of knowledge from academia to industry is one of the key drivers of this evolution. When research, entrepreneurial talent, and business vision align, companies emerge that are capable of competing in highly specialized global niches where barriers to entry are defined more by technological complexity, clinical validation, and regulatory pathways than by market access alone.

EpiicVet: veterinary innovation born from science

A representative example of this new stage is EpiicVet, a company founded as a university spin-off and focused on the development of implantable medical devices for veterinary medicine.

Its approach targets complex respiratory pathologies in companion animals, an area where technological solutions have historically been limited and often adapted from human medicine rather than designed specifically for veterinary use. This is particularly relevant given that respiratory conditions represent a clinically significant and under-served segment within companion animal health, where treatment options remain constrained by anatomical and technological limitations. Through proprietary design, intellectual property, and an evidence-based clinical approach, the company reflects how innovation can emerge from traditionally non-technological sectors while addressing clearly unmet clinical needs.

Beyond this specific case, initiatives like this highlight a broader trend: extreme specialization opens real opportunities for growth, differentiation, and international expansion, particularly in segments where clinical complexity is increasing faster than the availability of tailored solutions.

The evolution of animal health confirms a broader trend: traditionally established sectors are undergoing accelerated technological sophistication. What was once a fragmented and largely generalist field is gradually converging into a more structured innovation ecosystem.

The sector now combines scientific talent, entrepreneurial capability, and a growing industrial base capable of supporting global scaling. Companies like EpiicVet illustrate how, when knowledge and execution align, highly specialized projects can evolve into scalable solutions with real clinical and international impact.